Exhibit 10.1


 


Cooperation
Agreement


 


Party A: Shenzhen Saikun Biotechnology
Co., Ltd.


Legal Representative: Chunjie Zhang


 


Party B: Jiashierle (Xiamen) Health Science
& Technology Co., Ltd.


Legal Representative: TAN HUNG SENG


 


In the light of:


 


1. Both Party A and
Party B are enterprises legally established and existing under the laws of PRC. Shanghai Kangzi Pharmaceutical Science & Technology
Co., Ltd. is a subsidiary of Party B with its shares controlled by Party B (as of the date of this Agreement, Party B holds 60%
of shares). The quantized spatial power chamber (hereinafter collectively “remedial chambers”) developed by Shanghai
Kangzi Pharmaceutical Science & Technology Co., Ltd. is in the term of clinical trial.


 


2. Both Party A and
Party B have abundant knowledge about the application and marketing prospects of remedial chambers and have reached agreements
on the clinical trial and marketing promotion of remedial chambers.


 






    -1-


     


    

 


Therefore, for facilitating
the progress of clinical cooperation and advertising the remedial chambers to market as soon as possible, Party A and Party B have
reached the following agreements through negotiation:


 


1. Forms and Contents of
Cooperation


 


The Party A shall provide
support funds of five million and fifty thousand RMB (¥5,500,000) for the cooperation, while Party B shall be responsible
for selecting and purchasing raw materials of remedial chambers as well as providing one assembled equipment for clinical
trial. After fulfilling the payment of whole funds, Party A shall have the rights of use and the derivative interests.


 


2. Payment of
Funds


 


2.1 Time of Payment


 


2.1.1 Both Party A and
Party B have confirmed that Party A has paid the first sum of funds of one million and fifty thousand RMB (¥1,500,000)
to the account designated by Party B on September 7th 2019 and have paid one million and fifty thousand RMB (¥1,500,000)
to the account designated by Party B on September 27th 2019. As of the date of signing this Agreement, Party A has paid a total
of three million RMB (¥3,000,000) for cooperation support funds.


 






    -2-


     


    

 


2.1.2 As Party A agreed,
it shall pay two million and fifty thousand RMB (¥2,500,000) to Party B before October 15th 2019.


 


2.2 Payment Method


 


2.2.1 Party shall pay
the support funds aforesaid to the account designated by Party B as followed:


Name of Account: Jiashierle
(Xiamen) Health Science & Technology Co., Ltd.


Account Number: 403210
010400 XXXXX


Opening Bank: Agricultural
Bank of China Xiamen Jimei Subbranch


 


2.2.2 In the event Party
A requests Party B to provide bills, Party A shall provide official proof on relationships between payer and Party A (or its legal
representative), in order for Party B to provide bills.


 






    -3-


     


    

 


3. Rights and Obligations


 


3.1 Installation and
Transportation. Party B shall finish purchasing required raw materials for one remedial chamber and hereby installing and transporting
to the place designated by Party B as known and agreed by Party A, within 30 days after receiving total support funds of five
million and fifty thousand RMB (¥5,500,000) that shall be paid by Party A, and to complete equipment testing and
other work.


 


3.2 Clinical Trial


 


3.2.1 As agreed by both
Party, a clinical trial no less than one month shall be carried out, after the installation and adjustment of the remedial chamber.


 


3.2.2 During clinical
trial, Party B shall be responsible for training operators required for clinical trial to operate remedial chamber equipment skillfully.


 






    -4-


     


    

 


3.2.3 Party A shall
be responsible for coordinating with official competent authority to ensure that such remedial chamber can normally carry out clinical
trials at the site provided by Party A and shall be responsible for providing operators and site administrators required for clinical
trials and arranging corresponding medical personnel. During the trial period, all expenses of relevant staff such as salary, training
expenses, labor and social security expenses shall be borne by Party A.


 


3.2.4 Both Party A and
Party B have obligation to provide clinical cases required for clinical trials in accordance with standards, to invite presidents
of regional major hospitals to observe and experience in the test site during the trial period. Party A shall assist clinical hospitals
with relevant clinical work and shall bear the costs and enjoy the benefits. Party B shall actively cooperate in introduction for
patient and follow-up maintenance during the clinical trial period.


 






    -5-


     


    

 


3.3 Both parties agree
that when Party A has been able to operate and manage the remedial chamber equipment independently, Party A may request the equipment
to be modified to the place designated by Party A, provided that the place shall meet clinical conditions.


 


3.4 The warranty period
of the remedial chamber is one year, counting from the date when the remedial chamber is transported to the designated place. During
the warranty period, in the event Party A requests to upgrade and transform the equipment, the relevant expenses shall be borne
by Party A. Party A shall be responsible for assisting and cooperating in relevant installation work and providing logistic and
financial support for the life of relevant staff.


 


3.5 After the completion
of the clinical trial, Party B shall be responsible for acquiring relevant certificates and licenses required for producing remedial
chamber. Party B shall be responsible for ensuring relevant certificates and licenses to be attached to the remedial chamber equipment
used for clinical cooperation after relevant certificates and licenses being obtained. In the event Party A requests to upgrade
or transform the equipment, Party B shall provide support and assistance, and the relevant expenses shall be borne by Party A.
Party A shall conduct independent management and clinical services under the guidance of Party B.


 






    -6-


     


    

 


4. Intellectual Property and
Confidentiality


 


4.1 The relevant intellectual
property rights of the remedial chamber shall always belong to Party B, and Party A shall never infringe upon.


 


4.2 During project cooperation,
staff from each party who get exposure to the equipment must sign a confidentiality agreement with Party B before entering the
site to work. In the event the project cooperation is suspended or expired with no more cooperation, Party A shall have the right
of use and disposal of the equipment invested during the cooperation on the premise of ensuring Party B’s intellectual property
rights never being infringed.


 


5. Dispute Resolution


 


5.1 The law of the PRC
shall be applicable to this Agreement.


 






    -7-


     


    

 


5.2 Any dispute arising
out of or in connection with performance of this Agreement shall be settled through negotiation, if no agreement is reached each
Party has the right to initiate litigation in court of competent jurisdiction in Shenzhen.


 


6. Miscellaneous


 


6.1 This Agreement shall
come into effect as of the date of the first sum of funds of one million and fifty thousand RMB (¥1,500,000) paid by
Party A getting into the account designated by Party B.


 


6.2 Issues not covered
in this Agreement shall be supplemented by both parties in written form. The supplementary agreements shall have the same legal
effect as this Agreement.


 


6.3 Any other oral or
written memorandum or agreement between Party A and Party B on this cooperation project shall be repealed, and this Agreement prevails.


 






    -8-


     


    

 


6.4 This Agreement shall
be written in Chinese and English versions. Whereas the Chinese and English versions are contradictory, the Chinese version shall
prevail.


 


6.5 This Agreement is
made in quadruplicate, with each Party holding two copies respectively, and each copy has the same legal effect.


 


(No text below)


 






    -9-


     


    

 


(This
page is only for the purpose of the signature of this Agreement)


 


Party
A: Shenzhen Saikun Biotechnology Co., Ltd. (Seal)


Legal
Representative: Chunjie Zhang


Date:


 


Party
B: Jiashierle (Xiamen) Health Science & Technology Co., Ltd. (Seal)


Legal
Representative: TAN HUNG SENG


Date:


 





	Signed
    at:	 _________________________________




 


 


-10-